Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chicken pox vaccine OK for children with kidney disease

18.12.2002


Researchers at the Johns Hopkins Children’s Center report that two doses of the varicella vaccine for chicken pox given one to two months apart can be safe and effective in children with chronic kidney disease.



The findings, reported in the January issue of Pediatric Nephrology, are critical for chronic kidney disease patients, particularly children who will eventually undergo a kidney transplant. After transplantation, immunosuppressive medications put these children at high risk for severe chicken pox complications, including pneumonia, brain inflammation, and death.

"We recommend pediatric nephrologists include chicken pox vaccination as an important component of pre-end-stage renal disease and end-stage renal disease care," said the study’s lead author, Susan L. Furth, M.D, Ph.D., a pediatric nephrologist at the Children’s Center.


Varicella vaccine contains small doses of weakened strains of the chicken pox virus that activate immune system "memory" and mount a protective response to subsequent exposures.

In healthy children under 12 years of age, vaccination in a single dose is recommended, while two doses are recommended for adolescents. Without vaccination, infections in children whose immune systems have been weakened by a genetic disorder, disease, or medical treatment can cause serious complications.

In a multi-center, prospective, three-year clinical trial, Hopkins researchers, with the cooperation of the Southwest Pediatric Nephrology Study Group, identified 96 children with chronic kidney disease with no history of chicken pox. About half of these patients did not have detectable varicella antibodies. Each child received two injections of varicella vaccine, rather than the one dose typically given to healthy children. The doses were administered four to eight weeks apart.

One child developed chicken pox following a known exposure. There were no reported serious side effects following vaccination. Eleven patients developed a rash associated with the vaccine, and seven patients reported mild to moderate redness or soreness at the site of injection.

Over three years of follow-up, researchers report each child – including 16 children who received kidney transplants following vaccination – maintained the varicella antibody, and 87 percent retained antibody levels for more than three years. Although kidney transplant recipients tended to have lower varicella antibody levels during the first two years of follow-up, researchers report that antibody levels increased over time.


Children’s Center pediatric nephrologist Barbara A. Fivush, M.D., and researchers from the Johns Hopkins Bloomberg School of Public Health, Columbia Hospital at Medical City, and Merck & Co. contributed to the report. The study was funded by a grant from Merck & Co.

Jessica Collins | EurekAlert!
Further information:
http://www.hopkinsmedicine.org

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>